Curr Probl Cardiol . Impact of COVID-19 on Outcomes of Patients Hospitalized with STEMI: A Nationwide Propensity-Matched Analysis

[tetano]

Curr Probl Cardiol


. 2022 Dec 14;101547.
doi: 10.1016/j.cpcardiol.2022.101547. Online ahead of print.
Impact of COVID-19 on Outcomes of Patients Hospitalized with STEMI: A Nationwide Propensity-Matched Analysis


Akshay Goel ¹ , Aaqib H Malik ² , Dhrubajyoti Bandyopadhyay ² , Ameesh Isath ² , Rahul Gupta ³ , Adrija Hajra ⁴ , Rishi Shrivastav ⁵ , Salim S Virani ⁶ , Gregg C Fonarow ⁷ , Carl J Lavie ⁸ , Srihari S Naidu ²



Affiliations

• PMID: 36528206
• DOI: 10.1016/j.cpcardiol.2022.101547

Abstract

Introduction: Patients with ST-segment elevation myocardial infarction (STEMI) and concurrent coronavirus disease 2019 (COVID-19) have been reported to have poor outcomes. However, previous studies are small and limited.
Methods: The National Inpatient Sample (NIS) database for the year 2020 was queried to identify all adult hospitalizations with a primary diagnosis of STEMI, with and without concurrent COVID-19. A 1:1 propensity score matching was performed.
Results: A total of 159,890 hospitalizations with a primary diagnosis of STEMI were identified. Of these, 2,210 (1.38%) had concurrent COVID-19. After propensity matching, STEMI patients with concurrent COVID-19 had a significantly higher mortality (17.8% vs 9.1%, OR 1.96, p <0.001), lower likelihood to receive same-day percutaneous coronary intervention (PCI) (63.6% vs 70.6%, p = 0.019), with a trend towards lower overall PCI (74.9% vs 80.2%, p = 0.057) and significantly lower coronary artery bypass grafting (CABG) (3.0% vs 6.8%, p = 0.008) prior to discharge, compared with STEMI patients without COVID-19. The prevalence of cardiogenic shock, need for mechanical circulatory support, extracorporeal membrane oxygenation (ECMO), cardiac arrest, acute kidney injury (AKI), dialysis, major bleeding and stroke were not significantly different between the groups. COVID-19-positive STEMI patients who received same-day PCI had significantly lower odds of in-hospital mortality (adjusted OR 0.42, 95% CI 0.20-0.85, p = 0.017).
Conclusion: STEMI patients with concurrent COVID-19 infection had a significantly higher (almost two times) in-hospital mortality, and lower likelihood of receiving same-day PCI, overall (any-day) PCI, and CABG during their admission, compared with STEMI patients without COVID-19.

Keywords: COVID-19; STEMI; myocardial infarction.